These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2451448)

  • 21. Some studies on the isolation and properties of pulmonary mast cells from the pig.
    Leung KB; Marath A; Williams T; Drew CE; Pearce FL
    Agents Actions; 1988 Apr; 23(3-4):221-2. PubMed ID: 2455995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. General anaesthetics induce only histamine release selectively from human mast cells.
    Stellato C; Casolaro V; Ciccarelli A; Mastronardi P; Mazzarella B; Marone G
    Br J Anaesth; 1991 Dec; 67(6):751-8. PubMed ID: 1722691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allergic sensitisation of human lung fragments prevented by saturation of IgE binding sites.
    Godfrey RC; Gradidge CF
    Nature; 1976 Feb; 259(5543):484-6. PubMed ID: 56711
    [No Abstract]   [Full Text] [Related]  

  • 24. 6,9-deepoxy-6,9-(phenylimino)-delta 6,8-Prostaglandin I1, (U-60,257) stimulates prostaglandin D2 and inhibits thromboxane B2 release from ionophore challenged human dispersed lung cells.
    Holgate ST; Robinson C
    Br J Pharmacol; 1984 Nov; 83(3):603-5. PubMed ID: 6439267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Action of 3-isobutyl-1-methylxanthine and prostaglandins D2 and E1 on histamine release from rat and guinea pig mast cells.
    Ennis M; Robinson C; Dollery CT
    Int Arch Allergy Appl Immunol; 1983; 72(4):289-93. PubMed ID: 6196300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Licarin A is a candidate compound for the treatment of immediate hypersensitivity via inhibition of rat mast cell line RBL-2H3 cells.
    Matsui T; Ito C; Masubuchi S; Itoigawa M
    J Pharm Pharmacol; 2015 Dec; 67(12):1723-32. PubMed ID: 26376734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterogeneity of human mast cells.
    Schulman ES; Kagey-Sobotka A; MacGlashan DW; Adkinson NF; Peters SP; Schleimer RP; Lichtenstein LM
    J Immunol; 1983 Oct; 131(4):1936-41. PubMed ID: 6194221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Release of histamine and formation of prostaglandins in human lung tissue and rat mast cells.
    Strandberg K; Mathé AA; Yen SS
    Int Arch Allergy Appl Immunol; 1977; 53(6):520-9. PubMed ID: 68007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the modulatory effect of ketotifen, sodium cromoglycate, procaterol and salbutamol in human skin, lung and tonsil mast cells.
    Okayama Y; Church MK
    Int Arch Allergy Immunol; 1992; 97(3):216-25. PubMed ID: 1375203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiographic contrast media-induced histamine release: a comparative study with mast cells from different species.
    Amon EU; Ennis M; Schnabel M; Schneider C; Lorenz W
    Agents Actions; 1989 Apr; 27(1-2):104-6. PubMed ID: 2473613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Release of histamine from human skin induced by intracutaneous injection of adenosine-5'-triphosphate.
    Hägermark O; Diamant B; Dahlquist R
    Int Arch Allergy Appl Immunol; 1974; 47(2):167-74. PubMed ID: 4137166
    [No Abstract]   [Full Text] [Related]  

  • 32. Mast cells and their mediators.
    Marom Z; Casale TB
    Ann Allergy; 1983 Jun; 50(6):367-70. PubMed ID: 6190421
    [No Abstract]   [Full Text] [Related]  

  • 33. Anaphylactic release of thromboxane A2, prostaglandin D2, and prostacyclin from human lung parenchyma.
    Schulman ES; Newball HH; Demers LM; Fitzpatrick FA; Adkinson NF
    Am Rev Respir Dis; 1981 Oct; 124(4):402-6. PubMed ID: 6170242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of inflammatory mediator release from purified human lung mast cells.
    Schleimer RP; MacGlashan DW; Peters SP; Pinckard RN; Adkinson NF; Lichtenstein LM
    Am Rev Respir Dis; 1986 Apr; 133(4):614-7. PubMed ID: 3485946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of human basophils and mast cells in the pathogenesis of allergic diseases.
    Schleimer RP; Fox CC; Naclerio RM; Plaut M; Creticos PS; Togias AG; Warner JA; Kagey-Sobotka A; Lichtenstein LM
    J Allergy Clin Immunol; 1985 Aug; 76(2 Pt 2):369-74. PubMed ID: 2410478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolation and characterization of human intestinal mucosal mast cells.
    Fox CC; Dvorak AM; Peters SP; Kagey-Sobotka A; Lichtenstein LM
    J Immunol; 1985 Jul; 135(1):483-91. PubMed ID: 2582045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mediator release from human lung mast cell subtypes in chronic bronchitis and emphysema.
    van Overveld FJ
    Agents Actions; 1989 Apr; 27(1-2):97-100. PubMed ID: 2473645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxatomide inhibits the release of proinflammatory mediators from human basophils and mast cells.
    Patella V; de Crescenzo G; Marino O; Spadaro G; Genovese A; Marone G
    Int Arch Allergy Immunol; 1996 Sep; 111(1):23-9. PubMed ID: 8753840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The pharmacologic control of mediator release from human basophils and mast cells.
    Peters SP; Naclerio RM; Schleimer RP; MacGlashan DW; Pipkorn U; Lichtenstein LM
    Respiration; 1986; 50 Suppl 2():116-22. PubMed ID: 3494282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies with purified human basophils and mast cells.
    Lichtenstein LM; Schleimer RP; Peters SP; Kagey-Sobotka A; Adkinson NF; Adams GK; Schulman ES; MacGlashan DW
    Monogr Allergy; 1983; 18():259-64. PubMed ID: 6196631
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.